Skip to main content
Journal of Nanobiotechnology logoLink to Journal of Nanobiotechnology
. 2023 Nov 18;21:433. doi: 10.1186/s12951-023-02199-1

Correction: Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy

Seyed Hossein Kiaie 1,2,✉, Hossein Salehi‑Shadkami 1,3, Mohammad Javad Sanaei 4, Marzieh Azizi 5, Mahdieh Shokrollahi Barough 6, Mohammad Sadegh Nasr 7, Mohammad Sheibani 8,9,✉
PMCID: PMC10657613  PMID: 37980526

Correction: Journal of Nanobiotechnology (2023) 21:339 https://doi.org/10.1186/s12951-023-02083-y

The graphic abstract was missing from this article (and should have appeared as below).graphic file with name 12951_2023_2199_Figa_HTML.jpg

The original article has been revised.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Seyed Hossein Kiaie, Email: hosseinkiaie@gmail.com, Email: s.kiaie@renap.ir.

Mohammad Sheibani, Email: Mohammad.sheibani89@gmail.com, Email: sheibany.m@iums.ac.ir.

Reference

  • 1.Kiaie SH, Salehi-Shadkami H, Sanaei MJ, Azizi M, Shokrollahi Barough M, Nasr MS, Sheibani M. Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy. J Nanobiotechnology. 2023;21(1):339. doi: 10.1186/s12951-023-02083-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Nanobiotechnology are provided here courtesy of BMC

RESOURCES